FR2208656B1 - - Google Patents

Info

Publication number
FR2208656B1
FR2208656B1 FR7328680A FR7328680A FR2208656B1 FR 2208656 B1 FR2208656 B1 FR 2208656B1 FR 7328680 A FR7328680 A FR 7328680A FR 7328680 A FR7328680 A FR 7328680A FR 2208656 B1 FR2208656 B1 FR 2208656B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7328680A
Other versions
FR2208656A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FR2208656A1 publication Critical patent/FR2208656A1/fr
Application granted granted Critical
Publication of FR2208656B1 publication Critical patent/FR2208656B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR7328680A 1972-08-07 1973-08-06 Expired FR2208656B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27829272A 1972-08-07 1972-08-07

Publications (2)

Publication Number Publication Date
FR2208656A1 FR2208656A1 (fr) 1974-06-28
FR2208656B1 true FR2208656B1 (fr) 1977-11-10

Family

ID=23064436

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7328680A Expired FR2208656B1 (fr) 1972-08-07 1973-08-06

Country Status (6)

Country Link
US (1) US4064248A (fr)
AU (1) AU5884473A (fr)
BE (1) BE803325A (fr)
DE (1) DE2339893A1 (fr)
FR (1) FR2208656B1 (fr)
ZA (1) ZA735221B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096271A (en) * 1977-08-03 1978-06-20 American Cyanamid Company Slow release injectable formulations of tetramisole and derivatives in benzyl benzoate
US6727278B1 (en) * 1986-08-27 2004-04-27 Dms Pharmaceutical Inc. Pharmaceutically active agents that impede amyloid formation in vivo
GB8630419D0 (en) * 1986-12-19 1987-01-28 Fisons Plc Pharmaceutical formulation
AU763945B2 (en) * 1999-06-04 2003-08-07 Skyepharma Inc. Oil-core compositions for the sustained release of hydrophobic drugs
US20040213837A1 (en) * 2002-08-05 2004-10-28 Sankaram Mantripragada Oil-core compositions for the sustained release of hydrophobic drugs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1147760A (en) * 1965-06-17 1969-04-10 Sterling Drug Inc Heterocyclic nitrogen compounds
IE35639B1 (en) * 1970-10-05 1976-04-14 Ici Ltd Pyridoquinoline derivatives

Also Published As

Publication number Publication date
ZA735221B (en) 1974-07-31
US4064248A (en) 1977-12-20
BE803325A (fr) 1974-02-07
AU5884473A (en) 1975-02-06
DE2339893A1 (de) 1974-02-21
FR2208656A1 (fr) 1974-06-28

Similar Documents

Publication Publication Date Title
JPS5724508B2 (fr)
FR2208656B1 (fr)
JPS535955B2 (fr)
FR2193893B1 (fr)
JPS4979484A (fr)
FR2209834A1 (fr)
JPS49102276U (fr)
JPS495411A (fr)
JPS48104143A (fr)
JPS5148687B2 (fr)
JPS5320927B2 (fr)
CS156687B1 (fr)
CS156012B1 (fr)
RO57944A2 (fr)
JPS4890737A (fr)
JPS4939128U (fr)
CS150890B1 (fr)
CS154504B1 (fr)
CS163434B1 (fr)
CS163433B1 (fr)
CS163386B1 (fr)
CS159442B1 (fr)
CS157994B1 (fr)
CS152039B1 (fr)
CS156329B1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse